The weekly litigation news digest is live. Subscribe now

IP Verse

Microrna Target Site Blocking Oligos And Uses Thereof - EP2113567

The patent EP2113567 was granted to Exiqon on Apr 3, 2019. The application was filed on Dec 21, 2007 under application number EP09165187A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2113567

EXIQON
Application Number
EP09165187A
Filing Date
Dec 21, 2007
Status
Opposition Rejected
Mar 18, 2022
Publication Date
Apr 3, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
RANGER BIOTECHNOLOGIESJan 3, 2020BUDDE SCHOUADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONWO2008061537
OTHERWO2008061537
SEARCHCN101054576
SEARCHCN101054580
SEARCHUS2007065840
SEARCHWO2005111211
SEARCHWO2006069584

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents